138 results on '"Nagase, Michitaka"'
Search Results
2. BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS).
3. O5-3 Expert training workshop on support for balancing cancer treatment and work organized by West Japan Oncology Group
4. O14-1 A randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer: WJOG8315G
5. First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study
6. Advances in Immune Checkpoint Inhibitor That Physicians Need to Know
7. Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan
8. A randomized phase II trial of paclitaxel plus ramucirumab versus nab-paclitaxel plus ramucirumab for gastric cancer with peritoneal dissemination refractory to first-line therapy (WJOG10617G/P-SELECT).
9. Phase II study of FOLFOX4 with “wait and go” strategy as first-line treatment for metastatic colorectal cancer
10. Retrospective analysis of the international standard-dose FOLFIRI (plus bevacizumab) regimen in Japanese patients with unresectable advanced or recurrent colorectal carcinoma
11. A patient with esophageal squamous cell carcinoma who had a complete pathological response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil
12. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer
13. A clinicopathological study of basaloid squamous carcinoma of the esophagus
14. P3-6-4 - Efficacy and safety of etoposide in patients with platinum-pretreated metastatic or recurrent urothelial cancer
15. Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma
16. Epithelioid hemangioendothelioma of the liver
17. First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: A phase II study
18. A Multi-center Retrospective Analysis of Survival Benefits of Chemotherapy for Unresectable Biliary Tract Cancer
19. Early Phase II Study of Uracil–Tegafur Plus Doxorubicin in Patients with Unresectable Advanced Biliary Tract Cancer
20. Phase I Study of Fixed Dose Rate Infusion of Gemcitabine in Patients with Unresectable Pancreatic Cancer
21. Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinoma
22. Phase II Study of Radiotherapy Employing Proton Beam for Hepatocellular Carcinoma
23. Impact of gemcitabine on the treatment of metastatic pancreatic cancer
24. A Phase I Study of Hepatic Arterial Infusion Chemotherapy with Zinostatin Stimalamer Alone for Hepatocellular Carcinoma
25. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma
26. Hyperprogressive disease during nivolumab chemotherapy in metastatic gastric cancer: Multicenter retrospective study in Japan.
27. A Lethal Case due to Progressive Pulmonary Hypertension Presenting with Mediastinal, Hilar and Inguinal Lymphadenopathy and Pulmonary Interstitial Shadow on Chest CT
28. aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
29. A case of cancer education for high school students who joined the cancer awareness event in a community hospital
30. Phase II trial of panitumumab with irinotecan as salvage therapy for patients with advanced or recurrent colorectal cancer (TOPIC study)
31. aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
32. The Flow Rate Change Caused by Safety Huber-pointed Needle in Cancer Chemotherapy
33. Efficacy and safety of etoposide in patients with platinum-pretreated metastatic or recurrent urothelial cancer
34. Prognostic index model for overall survival in advanced unresectable pancreatic cancer from GEST study
35. Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer
36. Multicenter retrospective analysis for elderly patients with advanced gastric cancer (AGC) received first-line chemotherapy in clinical practice.
37. Investigation of Drug Interaction Between Warfarin and Gemcitabine -Increase in Anticoagulant Effect of Warfarin-
38. OP1-9 - A case of cancer education for high school students who joined the cancer awareness event in a community hospital
39. Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial
40. XELOX with bevacizumab in elderly patients age 75 or older with metastatic colorectal cancer: Results of a planned interim analysis for multicenter phase II ASCA study.
41. A Multicenter Phase II Trial of S-1 With Concurrent Radiation Therapy for Locally Advanced Pancreatic Cancer
42. Therapeutic strategies for synchronous and multiple liver metastases from colorectal cancer
43. Mo1949 Characteristics of Long-Term Survivors With Unresectable Colorectal Liver Metastases Down-Staged by Chemotherapy Followed by Liver Resection
44. ISS1-3-2 - Prognostic index model for overall survival in advanced unresectable pancreatic cancer from GEST study
45. A Phase I Study of Combination Chemotherapy with Gemcitabine and Oral S-1 for Advanced Pancreatic Cancer
46. Chemotherapy in the Treatment of Advanced Gallbladder Cancer
47. Evaluation of Contrast Enhancement Patterns in Pancreatic Tumors by Coded Harmonic Sonographic Imaging With a Microbubble Contrast Agent
48. P1-27-6 - Investigation of Drug Interaction Between Warfarin and Gemcitabine -Increase in Anticoagulant Effect of Warfarin-
49. A case of temporary pancytepenia with hypotrophic bone marrow after operation for bile duct cancer.
50. A CASE OF A COMMON BILE DUCT CANCER ASSOCIATED WITH CLONORCHIASIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.